Published in J Stroke Cerebrovasc Dis on October 01, 2007
Hemispheric differences in ischemic stroke: is left-hemisphere stroke more common? J Clin Neurol (2013) 0.84
Cognitive dysfunction after on-pump operations: neuropsychological characteristics and optimal core battery of tests. Stroke Res Treat (2014) 0.76
Cognitive profile of elderly patients with mild stroke. Dement Geriatr Cogn Dis Extra (2011) 0.75
Prefrontal-Parietal White Matter Volumes in Healthy Elderlies Are Decreased in Proportion to the Degree of Cardiovascular Risk and Related to Inhibitory Control Deficits. Front Psychol (2017) 0.75
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
[Diffusion-weighted MR in transient ischemic attacks]. Tidsskr Nor Laegeforen (2015) 3.21
A high-density screen for linkage in multiple sclerosis. Am J Hum Genet (2005) 2.50
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: no. Mult Scler (2013) 1.67
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. Lancet Neurol (2009) 1.58
Risk of MS is not associated with exposure to crude oil, but increases with low level of education. Mult Scler (2011) 1.54
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Mult Scler (2012) 1.50
Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting. J Cardiothorac Vasc Anesth (2004) 1.45
[Patients with acute cerebral infarction admitted to stroke unit]. Tidsskr Nor Laegeforen (2011) 1.45
Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders. Neurology (2014) 1.45
Retracted [Optic neuritis--diagnosis, treatment and follow up]. Tidsskr Nor Laegeforen (2005) 1.43
[a woman with recurrence of venous and arterial thrombosis]. Tidsskr Nor Laegeforen (2011) 1.39
[New diagnostic criteria in multiple sclerosis]. Tidsskr Nor Laegeforen (2003) 1.38
Cerebral arterial vasospasm. Tidsskr Nor Laegeforen (2011) 1.38
[Stroke neurology and interdisciplinarity]. Tidsskr Nor Laegeforen (2011) 1.38
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment. Neurology (2012) 1.27
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort. Mult Scler (2013) 1.22
Demographic and geographic vascular risk factor differences in European young adults with ischemic stroke: the 15 cities young stroke study. Stroke (2012) 1.20
Health-related quality of life among young adults with ischemic stroke on long-term follow-up. Stroke (2006) 1.18
Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study. Eur J Cancer Prev (2008) 1.18
Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms. J Neurol Neurosurg Psychiatry (2007) 1.17
Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'. BMC Neurol (2009) 1.17
Fatigue among stroke patients on long-term follow-up. The Bergen Stroke Study. J Neurol Sci (2011) 1.16
Fatigue at long-term follow-up in young adults with cerebral infarction. Cerebrovasc Dis (2005) 1.15
ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch Neurol (2012) 1.15
Discriminating variable test and selectivity ratio plot: quantitative tools for interpretation and variable (biomarker) selection in complex spectral or chromatographic profiles. Anal Chem (2009) 1.10
[Re: Unethical of neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support]. Tidsskr Nor Laegeforen (2014) 1.08
Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol (2002) 1.08
[Re: What is good treatment of acute stroke?]. Tidsskr Nor Laegeforen (2015) 1.07
Progressive multifocal leucoencephalopathy in an immunocompetent patient with favourable outcome. A case report. BMC Neurol (2010) 1.05
A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. Eur J Hum Genet (2009) 1.05
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome. Mult Scler (2012) 1.04
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway. Mult Scler (2012) 1.04
European Stroke Organisation recommendations to establish a stroke unit and stroke center. Stroke (2013) 1.04
Occipital lobe infarctions are different. Vasc Health Risk Manag (2007) 1.02
Dietary vitamin D3 supplements reduce demyelination in the cuprizone model. PLoS One (2011) 1.02
The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke. BMC Neurol (2014) 1.02
Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993. Schizophr Res (2004) 1.00
How long can you keep working with benign multiple sclerosis? J Neurol Neurosurg Psychiatry (2010) 0.98
Instrumental assessment of atopic eczema: validation of transepidermal water loss, stratum corneum hydration, erythema, scaling, and edema. J Am Acad Dermatol (2006) 0.97
Poor sleep in patients with multiple sclerosis. PLoS One (2012) 0.95
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM. J Proteomics (2012) 0.95
Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol (2009) 0.93
Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab. Mult Scler (2011) 0.92
Diffusion-weighted lesions in stroke patients with transient symptoms--where are they located? Cerebrovasc Dis (2014) 0.92
Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Arch Neurol (2008) 0.92
Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway. J Neurol (2013) 0.92
Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. PLoS One (2013) 0.92
Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome. Proteomics Clin Appl (2007) 0.92
Serum albumin in ischemic stroke patients: the higher the better. The Bergen Stroke Study. Cerebrovasc Dis (2009) 0.91
A multivariate approach to reveal biomarker signatures for disease classification: application to mass spectral profiles of cerebrospinal fluid from patients with multiple sclerosis. J Proteome Res (2010) 0.91
Underfunding of stroke research: a Europe-wide problem. Stroke (2004) 0.90
Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway. Acta Neurol Scand (2010) 0.90
mtDNA nt13708A variant increases the risk of multiple sclerosis. PLoS One (2008) 0.90
Lipoatrophy: a non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosis. J Neurol (2006) 0.90
Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway. In Vivo (2010) 0.89
Risk factors and their impact on carotid intima-media thickness in young and middle-aged ischemic stroke patients and controls: the Norwegian Stroke in the Young Study. BMC Res Notes (2014) 0.88
Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study. BMC Neurol (2011) 0.87
No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Ann Neurol (2013) 0.87
Intracerebral hemorrhage in southern Norway--a hospital-based incidence study. Eur Neurol (2012) 0.87
Predictors for recanalization after intravenous thrombolysis in acute ischemic stroke. J Stroke Cerebrovasc Dis (2007) 0.86
C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients. J Stroke Cerebrovasc Dis (2013) 0.86
The Norwegian Stroke in the Young Study (NOR-SYS): rationale and design. BMC Neurol (2013) 0.86
Fcgamma receptor IIIA polymorphism as a risk-factor for coronary artery disease. Atherosclerosis (2005) 0.86
Biomarkers Related to Carotid Intima-Media Thickness and Plaques in Long-Term Survivors of Ischemic Stroke. Transl Stroke Res (2015) 0.85
Low body temperature associated with severe ischemic stroke within 6 hours of onset: The Bergen NORSTROKE Study. Vasc Health Risk Manag (2012) 0.85
Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms. J Neuroimmunol (2005) 0.85
Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination. Exp Neurol (2008) 0.85
Balance and gait improved in patients with MS after physiotherapy based on the Bobath concept. Physiother Res Int (2006) 0.85
[Treatment of cerebrovascular disease in a comprehensive stroke unit]. Tidsskr Nor Laegeforen (2011) 0.85
Elevated admission blood pressure and stroke severity in acute ischemic stroke: the Bergen NORSTROKE Study. Cerebrovasc Dis (2013) 0.84
Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations. Immunology (2005) 0.84
Antibodies against interferon-beta in multiple sclerosis. J Neuroimmunol (2009) 0.84
TNF-alpha and -beta gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF-beta gene. Autoimmunity (2002) 0.84
The effect of physiologic derangement in patients with stroke treated with thrombolysis. J Stroke Cerebrovasc Dis (2008) 0.84
Comparison between Ischemic Stroke Patients <50 Years and ≥50 Years Admitted to a Single Centre: The Bergen Stroke Study. Stroke Res Treat (2011) 0.84
Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. J Neurol (2008) 0.83
Arterial events after ischemic stroke at a young age: a cross-sectional long-term follow-up of patients and controls in western Norway. Cerebrovasc Dis (2007) 0.82
Pretreatment of mass spectral profiles: application to proteomic data. Anal Chem (2007) 0.82
Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients. J Neuroimmunol (2005) 0.82